Page last updated: 2024-10-26

dibucaine and Keratoconjunctivitis

dibucaine has been researched along with Keratoconjunctivitis in 2 studies

Dibucaine: A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
cinchocaine : A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lumholtz, IB1
Suhr, P1

Other Studies

2 other studies available for dibucaine and Keratoconjunctivitis

ArticleYear
[Drug information for nurses. Cincaine ophthalmic ointment 0.5 percent. Therapeutic action group: local analgesics].
    Sygeplejersken, 1976, Jul-21, Volume: 76, Issue:28

    Topics: Dibucaine; Humans; Keratoconjunctivitis; Ointments

1976
[Drug information. Cincaine eye ointment 0, 5%, Ferring].
    Ugeskrift for laeger, 1975, Dec-08, Volume: 137, Issue:50

    Topics: Dibucaine; Humans; Keratoconjunctivitis; Ointments

1975